3 Pharma Stocks Just Running in Place

Gobs of free cash flow doesn't mean a company is worth buying. Some companies, especially pharmaceuticals, just use cash to run in place. More 

3 Healthcare Stocks With Healthy Dividends

Protect yourself from the headwinds facing healthcare stocks by snatching up names that offer -- and are likely to keep offering -- big-time dividends. More 

Facebook Makes the Grade and Is Now a Buy

Yes, you read that correctly. After spending months in sell territory, Facebook has made a complete turnaround in a matter of days and is now a buy More 

74 Actions to Take For the Earnings Shakeout

Earnings season has kicked into high gear, and here is how to stay ahead of these 74 stocks More 

Ugly Fight at Obesity Drug Company Leads to New CEO

Vivus will settle a proxy battle with its largest shareholder by adding six board members and a new CEO backed by First Manhattan. More 

Study: Prilosec, Nexium, Prevacid May Lead to Heart Disease

A study by John P. Cooke published in American Heart Association journal, Circulation, links drugs like Prilosec and Prevacid to heart disease. More 

2 Major Pharmaceutical Rivals to Share Drug Data

AstraZeneca and Roche will share drug research data with a third company to build a compound library to accelerate drug development and lower costs. More